Which Medications Are Used for GLP-1 Weight Loss?
GLP3 Weight Loss is an independent educational resource and referral service — it does not prescribe, dispense, or sell weight-loss medications. This page explains the main medication classes a licensed provider may consider: GLP-1 receptor agonists and dual- or triple-agonist medications. Understanding the differences can help you have an informed conversation with an independent licensed provider.
GLP-1 Receptor Agonists
GLP-1 (glucagon-like peptide-1) medications are widely recognized for supporting weight loss. They mimic the natural GLP-1 hormone, which plays a key role in appetite regulation and blood sugar management. Semaglutide is a GLP-1 receptor agonist and is FDA-approved for weight management; tirzepatide is a dual GLP-1/GIP agonist that is also FDA-approved.
These medications are typically administered via once-weekly injection and have a strong clinical track record. They help reduce hunger signals, increase feelings of fullness, and slow gastric emptying. For many people, they are a proven first-line therapy with well-established safety profiles.
Dual- and Triple-Agonist Medications
Tirzepatide activates both GLP-1 and GIP receptors. Retatrutide is a triple agonist (GLP-1/GIP/glucagon) that is investigational and NOT FDA-approved. Published Phase 2 trial data (NEJM, 2023) reported substantial reductions in body weight, though it remains an investigational compound and individual outcomes are not established.
These medications are generally administered via once-weekly injection and work through overlapping pathways—reducing appetite, improving satiety, and supporting metabolic function. In trials, multi-receptor agonists produced larger reductions than GLP-1 alone for many participants.
How a Provider Chooses a Medication
During an initial consultation, an independent licensed provider reviews your medical history, current health status, and goals, and assesses eligibility for each medication type, considering factors like:
- Your past responses to similar treatments
- Any contraindications or medical conditions
- Your preference and comfort level with different options
- Insurance coverage and medication availability
- Expected timeline for achieving your goals
An independent licensed provider may recommend starting with a GLP-1 medication and adjusting from there. The choice is individualized based on clinical presentation and is made by the provider — not by GLP3 Weight Loss.
Monitoring and Adjustments
Once medication begins, an independent licensed provider typically monitors progress through regular check-ins. If results or tolerability are not as hoped, the provider can adjust the medication, dosage, or frequency. GLP3 Weight Loss does not monitor patients or manage medication.
For more information about medication options, find a licensed provider. You can also explore the frequently asked questions or review the educational documentation for additional clinical detail.
Disclaimer: GLP3 Weight Loss is an educational resource and referral service, not a provider or pharmacy; it does not prescribe, dispense, sell, or monitor medications. Semaglutide and tirzepatide are FDA-approved; retatrutide is investigational and not FDA-approved. Results vary; eligibility is determined by a licensed provider. These medications require ongoing provider oversight and are not appropriate for everyone.